6 pending office actions • 5 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Livingmed Biotech S.r.l. | 2 |
| Highlight Therapeutics, S.L. | 1 |
| Elisabeth Zeisberg | 1 |
| Merz Therapeutics GmbH | 1 |
| UNIVERSITÄT BIELEFELD | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18546427 | GENETICALLY MODIFIED CLOSTRIDIUM STRAINS EXPRESSING RECOMBINANT ANTIGENS AND USES THEREOF | Livingmed Biotech S.r.l. | FOLEY, SHANON A | 1671 | Non-Final OA | Aug 14, 2023 |
| 18349989 | NOVEL COMPOSITIONS BASED ON POLYINOSINIC-POLYCYTIDYLIC ACID | Highlight Therapeutics, S.L. | ZARA, JANE J | 1637 | Non-Final OA | Jul 11, 2023 |
| 17917958 | ALL-IN-ONE AAV VECTORS FOR TREATING CORONAVIRUS-INDUCED DISEASES | Elisabeth Zeisberg | HUDSON, AMY ROSE | 1636 | Final Rejection | Oct 10, 2022 |
| 17787381 | GENETICALLY MODIFIED CLOSTRIDIUM STRAINS AND USES THEREOF | Livingmed Biotech S.r.l. | SINGH, SATYENDRA K | 1657 | Final Rejection | Jun 20, 2022 |
| 17767725 | METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGE | Merz Therapeutics GmbH | DAVIS, RUTH A | 1699 | Non-Final OA | Apr 08, 2022 |
| 17642054 | METHOD FOR THE PRODUCTION OF RAAV AND METHOD FOR THE IN VITRO GENERATION OF GENETICALLY ENGINEERED, LINEAR, SINGLE-STRANDED NUCLEIC ACID FRAGMENTS CONTAINING ITR SEQUENCES FLANKING A GENE OF INTEREST | UNIVERSITÄT BIELEFELD | YAMASAKI, ROBERT J | 1657 | Non-Final OA | Mar 10, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial